A recent report from the Institute for Public Innovation takes an in-depth look at the impact of direct-to-consumer advertising on the pharmaceutical industry. The report cites
FDA statistics that reveal while government officials and physicians may be concerned about DTC promotions, consumers don't mind them. Seventy-two percent of respondents to the
FDA survey rejected the notion that prescription drug advertisements made it seem that a doctor wasn't needed to decide if the drug was right for them.
(IPI: Tom Giovanetti, 972/874-5139; FDA: http://www.fda.gov)